Wms Partners, LLC Novo Nordisk A S Transaction History

Wms Partners, LLC

$1.51 Billion
Q2 2024

A detailed history of Wms Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wms Partners, LLC holds 2,871 shares of NVO stock, worth $330,394. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,871

Previous 3,366 14.71%

Holding current value

$330,394

Previous $432,000 5.32%

% of portfolio

0.03%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $60,741 - $72,720	-495 Reduced 14.71%	2,871 $409,000
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $24,914 - $33,164	244 Added 7.82%	3,366 $432,000
Q4 2023 Feb 12, 2024	SELL	$87.78 - $105.45 $119,205 - $143,201	-1,358 Reduced 30.31%	3,122 $322,000
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $204,887 - $449,563	2,253 Added 101.17%	4,480 $407,000
Q1 2023 May 12, 2023	BUY	$132.34 - $159.14 $132 - $159	1 Added 0.04%	2,227 $354,000
Q4 2022 Feb 07, 2023	SELL	$102.55 - $135.33 $148,184 - $195,551	-1,445 Reduced 39.36%	2,226 $301,000
Q3 2022 Nov 08, 2022	SELL	$95.28 - $116.93 $392,363 - $481,517	-4,118 Reduced 52.87%	3,671 $366,000
Q2 2022 Aug 05, 2022	BUY	$103.24 - $121.81 $526,524 - $621,231	5,100 Added 189.66%	7,789 $868,000
Q1 2022 May 10, 2022	BUY	$93.1 - $112.54 $250,345 - $302,620	2,689 New	2,689 $299,000
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $198,561 - $225,855	-4,780 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $388,889 - $466,282	-8,020 Reduced 62.66%	4,780 $235,000
Q3 2017 Oct 27, 2017	SELL	$41.15 - $49.22 $823 - $984	-20 Reduced 0.16%	12,800 $616,000
Q2 2017 Aug 09, 2017	BUY	N/A	12,820	12,820 $550,000

Others Institutions Holding NVO

# of Institutions

1,990

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $260B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.

Account